Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Loratadine
Drug ID BADD_D01317
Description Loratadine is a second generation antihistamine used to manage symptoms of allergic rhinitis.[A176435] A lack of sedative and CNS adverse effects make loratadine, along with other second generation antihistamines, preferable over their 1st generation counterparts in many clinical situations.[A176441]
Indications and Usage Loratadine is a 2nd generation antihistamine and is used to manage symptoms of allergic rhinitis, wheal formation, urticaria, and other allergic dermatologic conditions.[A176435][A176438][L8486]
Marketing Status approved; investigational
ATC Code R06AX13
DrugBank ID DB00455
KEGG ID D00364
MeSH ID D017336
PubChem ID 3957
TTD Drug ID D06ABF
NDC Product Code 80070-110; 51927-4219; 59651-185; 63552-038; 65015-684; 11523-6655; 11523-7237; 11673-558; 21130-646; 36800-608; 36800-755; 37808-131; 41163-612; 41250-612; 41520-131; 43598-758; 49035-612; 49035-806; 51316-915; 53943-035; 55301-612; 56062-990; 57344-193; 58602-744; 58602-831; 59556-882; 59779-612; 0363-9937; 66715-6432; 67091-245; 67751-163; 68016-053; 68016-131; 68071-2801; 68071-2934; 68788-8349; 69230-328; 70000-0583; 70518-0135; 70518-1335; 70518-1399; 73581-203; 73581-230; 62331-018; 11523-7200; 11523-7202; 11822-0446; 11822-2022; 11822-8329; 41163-364; 46122-423; 49035-611; 50090-5506; 51316-503; 51660-106; 51660-526; 51672-2092; 55289-728; 55910-611; 55910-970; 56062-132; 57483-950; 59726-758; 60760-569; 62207-787; 0363-9994; 63941-131; 68016-167; 68071-2208; 68391-314; 68788-7291; 68998-414; 69452-211; 70518-2951; 70677-1053; 70985-017; 11014-0031; 62938-0005; 11523-0800; 11523-7157; 11673-115; 11673-612; 11822-0558; 11822-0919; 11822-3276; 21130-195; 21130-526; 21130-780; 21130-914; 21130-999; 0113-1019; 41250-629; 41250-890; 41520-716; 43598-756; 45802-650; 46122-539; 47682-203; 47682-403; 49035-953; 50090-4316; 50090-5067; 50090-5532; 50268-489; 51660-527; 51660-754; 54838-554; 55154-8082; 55681-303; 59726-915; 0363-2108; 0363-9150; 63941-193; 69168-414; 69230-317; 69230-322; 69842-085; 70000-0473; 55910-539; 55910-806; 59556-917; 62011-0248; 62011-0371; 0363-1612; 63548-0753; 0363-9603; 0363-9955; 63868-462; 0363-9995; 63868-669; 66715-6532; 67091-350; 68016-088; 68016-094; 68084-248; 69256-612; 0536-1367; 71335-0100; 0615-8217; 72983-500; 80070-120; 0904-6852; 59651-035; 11523-4328; 21130-301; 21130-452; 24385-543; 30142-017; 46122-550; 47682-913; 49348-818; 51672-2131; 51824-075; 53117-309; 55315-528; 58602-702; 58602-821; 58602-881; 61919-142; 63868-414; 63981-612; 67751-153; 68016-055; 68071-3412; 69842-686; 69842-894; 70000-0213; 82501-1580; 10888-8213; 61474-4268; 65015-803; 65691-0042; 66577-046; 11523-4329; 11523-4359; 11523-4364; 11673-986; 11673-996; 11822-0612; 0113-1191; 36800-853; 37205-378; 0113-9755; 41226-686; 41250-539; 43598-707; 51660-753; 55700-097; 57243-200; 60000-950; 63629-7772; 63868-151; 0378-8880; 67091-408; 68016-526; 68071-3414; 68210-4110; 69452-283; 69842-337; 69842-895; 70000-0125; 71335-1461; 72036-193; 72288-446; 72288-451; 72888-029; 10888-8212; 66577-012; 68554-0003; 11523-0007; 11523-4330; 11523-7333; 11822-9999; 16714-898; 30142-446; 0113-7671; 49035-061; 50090-1454; 51316-502; 51660-112; 51672-2085; 55154-4375; 56062-526; 57483-955; 58602-818; 58602-830; 58602-847; 59556-301; 62011-0348; 0363-0771; 0363-0858; 63187-100; 64024-023; 66715-9732; 68196-301; 68391-301; 68788-7653; 69842-242; 69842-540; 69842-953; 70264-030; 71309-007; 72983-501; 80159-103; 81522-612; 38779-2857; 51552-1210; 62993-0803; 63827-0001; 65015-802; 11523-1527; 11523-4331; 11523-7160; 11822-0620; 25000-021; 30142-723; 30142-984; 33992-0612; 0113-7612; 37808-506; 41520-612; 47682-912; 49738-686; 50090-6164; 50594-010; 52904-630; 54838-558; 55319-099; 55910-594; 59779-528; 0363-0752; 0363-0754; 63868-577; 68071-2971; 68998-309; 69168-309; 69848-019; 70000-0252; 70010-162; 70677-0029; 70677-0145; 71335-1651; 49452-4135; 11673-111; 11822-2131; 11822-7240; 16571-822; 30142-612; 0113-1719; 41250-716; 49035-538; 50090-0836; 53943-116; 53943-975; 56062-900; 62011-0305; 0363-0699; 0363-1686; 0363-2131; 0363-4020
UNII 7AJO3BO7QN
Synonyms Loratadine | 4-(8-Chloro-5,6-dihydro-11H-benzo(5,6)cyclohepta(1,2-b)pyridin-11-ylidene)-1-piperidinecarboxylic Acid Ethyl Ester | Claritin | Sch-29851 | Sch 29851 | Sch29851 | Alavert | Clarium
Chemical Information
Molecular Formula C22H23ClN2O2
CAS Registry Number 79794-75-5
SMILES CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Headache17.14.01.0010.000869%
Hepatic function abnormal09.01.02.0010.000080%Not Available
Hyperhidrosis23.02.03.004; 08.01.03.0280.000254%
Hyperkinesia17.01.02.008--Not Available
Hypersensitivity10.01.03.0030.000557%
Hypertension24.08.02.001--
Hyperthermia12.05.01.002; 08.05.01.0010.000032%Not Available
Hypoaesthesia23.03.03.081; 17.02.06.0230.000119%Not Available
Hypotension24.06.03.002--
Immune system disorder10.02.01.001--Not Available
Increased appetite08.01.09.027; 14.03.01.0030.000080%Not Available
Injection site erythema23.03.06.015; 12.07.03.001; 08.02.03.0010.000164%Not Available
Injection site pain12.07.03.011; 08.02.03.0100.000180%Not Available
Injection site reaction12.07.03.015; 08.02.03.0140.000109%
Injection site urticaria23.04.02.003; 12.07.03.029; 10.01.06.003; 08.02.03.0290.000109%Not Available
Insomnia19.02.01.002; 17.15.03.0020.000447%
Intentional self-injury19.12.01.002; 12.01.08.0360.000080%Not Available
Irritability19.04.02.013; 08.01.03.011--
Jaundice23.03.03.030; 09.01.01.004; 01.06.04.0040.000048%Not Available
Lacrimation increased06.08.02.0040.000109%
Laryngeal oedema10.01.05.003; 22.04.02.001; 23.04.01.0050.000048%
Lethargy19.04.04.004; 17.02.04.003; 08.01.01.0080.000064%
Loss of consciousness17.02.04.0040.000209%Not Available
Malaise08.01.01.0030.000373%
Menstruation delayed21.01.02.003; 05.05.01.010--Not Available
Middle insomnia19.02.01.003; 17.15.03.0030.000048%Not Available
Migraine24.03.05.003; 17.14.02.0010.000064%Not Available
Mood altered19.04.02.0070.000048%Not Available
Mouth ulceration07.05.06.0040.000048%Not Available
Myalgia15.05.02.0010.000142%
The 4th Page    First    Pre   4 5 6 7 8    Next   Last    Total 8 Pages